Anbenitamab in combination with chemotherapy in patients with HER2-positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC-WISE 01)
安贝尼单抗联合化疗治疗既往接受过含曲妥珠单抗治疗失败的 HER2 阳性胃癌或胃食管交界处癌患者:一项多中心 II 期研究 (KC-WISE 01)
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.70080
Zhao, Chuanhua; Zhao, Jun; Chen, Yigui; Liu, Bo; Du, Yangfeng; Li, Chenglin; Zhang, Jingdong; Yang, Mudan; Liu, Ying; Bai, Yuxian; Li, Suyi; Zhang, Ruixing; Ning, Fangling; Liu, Yanping; Zou, Kai; Zhang, Qi; Xie, Yijiao; An, Yuping; Xu, Jianming